Clinical Trials
2 trialsNCT02236546 2017-04-13
FDG-PET in Advanced Melanoma
Vanderbilt-Ingram Cancer Center
Phase NA Terminated
NCT00898742 2013-04-02
Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer
Vanderbilt-Ingram Cancer Center
Terminated